<DOC>
	<DOCNO>NCT03085251</DOCNO>
	<brief_summary>The objective study evaluation system accuracy base EN ISO 15197:2015 ( ISO 15197:2013 ) , clause 6.3 accuracy requirement applicable test procedure blood glucose monitoring system intend self-monitoring blood glucose patient stipulate . ISO 15197:20132 harmonize regulation European Union EN ISO 15197:2015 . This harmonization impact requirement procedu¬res ISO 15197:2013 ; change make foreword informative annex . In study , system accuracy evaluation perform OneTouch® Verio Flex ( LifeScan Europe ) behalf LifeScan Scotland Limited ( customer ) three different reagent system lot .</brief_summary>
	<brief_title>Clinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System ( BGMS )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Male female , type 1 diabetes , type 2 diabetes ( subject without diabetes ) Signed informed consent form Minimum age 18 year Subjects legally competent capable understand character , mean consequence study . If blood glucose value &lt; 80 mg/dl &gt; 300 mg/dl shall measure short term alteration insulin therapy : Male female type 1 diabetes intensified insulin therapy insulin pump therapy . Signature subject document consent procedure inform consent form . Pregnancy lactation period Severe acute disease ( study physician 's discretion ) Severe chronic disease potential risk test procedure ( study physician 's discretion ) Current constitution compromise subject 's capability participate study ( study physician 's discretion ) Being unable give inform consent &lt; 18 year Legally incompetent Being commit institution ( e.g . psychiatric clinic ) Language barrier potentially compromise adequate compliance study procedure Dependent investigator sponsor If blood glucose value &lt; 80 mg/dl shall measure short term alteration insulin therapy ( concentration category 2 ) , subject type 1 diabetes , suffering : Coronary heart disease Condition myocardial infarction Condition cerebral event Peripheral arterial occlusive disease Hypoglycemia unawareness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>